None listed
Conditions
Brief summary
The current study aims to assess the feasibility of the Triple P Positive Parenting Program for parents who have a child diagnosed with cancer. Who is it for? You may be eligible to join this study if you are an English-speaking parent of a child aged 2-8 years who has been diagnosed with acute lymphoblastic leukaemia (ALL), and is on the maintenance phase of treatment. Study details Participants in this study will be randomly (by chance) allocated to one of two groups. Participants in one group will undergo the Triple P Positive Parenting Program straight away. Participants in the other group will be offered the same program approximately 5 months later. Triple P is an evidence-based program developed specifically to provide parents with practical strategies for dealing with problem behaviour in their children. This intervention will be delivered in an online group format, hence making it accessible to all families regardless of their personal or geographic circumstances. Both intervention and control group parents will complete online surveys measuring parenting strategies, child sleep, child diet, child behaviour and other feasibility questionnaires at three timepoints (2 weeks prior to the first intervention, and again at 2 and 12 weeks post intervention completion). The results from this pilot intervention will be used to inform the development of a cancer-specific Triple P Intervention (CancerCare Triple P) for implementation across multiple paediatric oncology sites nationally.
Interventions
The current study aims to assess the feasibility of the Triple P Positive Parenting Program for parents who have a
child diagnosed with acute lymphoblastic leukaemia. Triple P is an evidence-based program developed specifically to provide parents with practical strategies for dealing with problem behaviour in their children.
Current research shows that parents of children being treated for childhood leukaemia have reported treatment related behavioural problems, including sleep, diet and genera
The current study aims to assess the feasibility of the Triple P Positive Parenting Program for parents who have a child diagnosed with acute lymphoblastic leukaemia. Triple P is an evidence-based program developed specifically to provide parents with practical strategies for dealing with problem behaviour in their children. Current research shows that parents of children being treated for childhood leukaemia have reported treatment related behavioural problems, including sleep, diet and general behaviour. Currently no evidence-based parenting interventions targeting these issues exist. The aim of the current study is pilot an existing evidence-based parenting intervention: Triple P - Positive Parenting Program (Group format for 0-12 year old children) using a live online meeting platform in order to: 1) assess the relevance of the intervention for paediatric cancer; 2) identify any modifications required to better tailor the program to the needs of parents of children with cancer; and 3) assess the feasibility of the live online delivery modality. The intervention will be delivered in an online group format therefore providing accessible and equitable parenting support for metropolitan, regional and rural families. The results from this pilot intervention will be used to inform the development of a cancer-specific Triple P Intervention (CancerCare Triple P) for implementation across multiple paediatric oncology sites nationally. Participants will be randomly allocated to an intervention (N=12) or control (N=12) arm. Intervention group parents will participate in a 9-week live online (5 x 1 hr face-to face via iPads and 4 x 30minuts via phone) group-based parenting intervention, facilitated by a TripleP trained Psychologist. Both intervention and control groups will complete online surveys measuring parenting strategies, child sleep, child diet, child behaviour and other feasibility questionnaires at three timepoints (2 weeks prior to the first intervention, and again at 2 and 12 weeks post intervention).
Sponsors
Murdoch Childrens Research Institution
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants will include English-speaking parents of a child who meets the following eligibility criteria: a) Is aged 2-8 years at the point of recruitment; b) Has been diagnosed with acute lymphoblastic leukaemia (ALL); c) Is on the maintenance phase of treatment; d) Has not relapsed and is not receiving palliative care; e) Has no other significant and unrelated medical condition (e.g. Autism, Down Syndrome).
Exclusion criteria
Parents/Caregivers will also be excluded from participating if deemed by the clinical treating team that the family should not be approached and also if their child: a) Is considered palliative; b) Has a neurological condition or major developmental disorder ; c) Does not reside with the parent at least part-time.
Outcome results
None listed